Provided by Tiger Trade Technology Pte. Ltd.

Titan Pharmaceuticals

4.61
0.0000
Volume:- -
Turnover:19.91M
Market Cap:6.13M
PE:-1.56
High:4.61
Open:4.61
Low:4.61
Close:4.61
52wk High:5.76
52wk Low:3.03
Shares:1.33M
Float Shares:723.50K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9464
EPS(LYR):-5.2347
ROE:-82.72%
ROA:-44.08%
PB:2.20
PE(LYR):-0.88

Loading ...

May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 27, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 21, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 31, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 08, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 03, 2020

Major Issues Report

8-K - Current report
Dec 01, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals